Our Businesses
Our Company
Jump to:
A Look Back on Our Work in 2020
Annual Shareholders Meeting Materials
Annual Shareholders Meeting Materials
Learn More
In early January 2020, it was impossible to guess exactly how the nascent pandemic would unfold. But Johnson & Johnson has been investing in and applying the best science to take on the most serious public health threats for more than a century—and there was never any question that we would contribute the full breadth and depth of our company’s expertise to global efforts to combat COVID-19.
The number of consecutive years that Johnson & Johnson has increased its shareholder dividend.
The amount, in billions of dollars, that Johnson & Johnson invested in research and development in 2020—up $800 million from 2019.
Robert Wood Johnson, former chairman from 1932 to 1963 and a member of the Company’s founding family, crafted Our Credo himself in 1943, just before Johnson & Johnson became a publicly traded company. This was long before anyone ever heard the term “corporate social responsibility.” Our Credo is more than just a moral compass. We believe it’s a recipe for business success. The fact that Johnson & Johnson is one of only a handful of companies that have flourished through more than a century of change is proof of that.